CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease

Soosung Kang, Garry Cooper, Sara F. Dunne, Brendon Dusel, Chi Hao Luan, D. James Surmeier, Richard B. Silverman

Research output: Contribution to journal › Article › peer-review

141 Scopus citations

Fingerprint

Dive into the research topics of 'CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science